RiceBran Technologies
RIBT
RIBT was delisted on the 7th of November, 2023.
13 hedge funds and large institutions have $4.7M invested in RiceBran Technologies in 2014 Q2 according to their latest regulatory filings, with 6 funds opening new positions, 3 increasing their positions, 0 reducing their positions, and 2 closing their positions.
1,213% more capital invested
Capital invested by funds: $358K → $4.7M (+$4.34M)
200% more first-time investments, than exits
New positions opened: 6 | Existing positions closed: 2
44% more funds holding
Funds holding: 9 → 13 (+4)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SM
Sabby Management
Miami Beach,
Florida
|
+$2.88M |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$790K |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$571K |
| 4 |
Goldman Sachs
New York
|
+$13.3K |
| 5 |
Citigroup
New York
|
+$8.98K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Ameriprise
Minneapolis,
Minnesota
|
-$53 |
RIBT Hedge Fund Activity: Q2 2014 in Review
13 of the 3,481 institutional investors tracked by Wall St. Rank reported a position in RiceBran Technologies (RIBT) for Q2 2014, worth a combined $4.7M — up 1,213% from $358K a quarter earlier.
Buyers outnumbered sellers: 6 funds opened new RIBT positions and 2 closed out — a net gain of 4 holders — while 3 added to existing stakes and 0 trimmed.
The largest buyer was Sabby Management, opening a new position worth an estimated $2.88M. The largest seller was Ameriprise, exiting entirely with an estimated $53 sold.
- 13 institutional investors held RiceBran Technologies (RIBT) as of Q2 2014, up from 9 in Q1 2014.
- Funds reported $4.7M of RiceBran Technologies stock for Q2 2014, up 1,213% quarter-over-quarter.
- 6 funds opened new RiceBran Technologies positions in Q2 2014 and 2 closed out, a net change of +4 holders.
- The largest RiceBran Technologies buyer in Q2 2014 was Sabby Management, an estimated $2.88M added.
- The largest RiceBran Technologies seller in Q2 2014 was Ameriprise, an estimated $53 sold.
Based on aggregated 13F filings for Q2 2014.